Last updated on December 2018

Merestinib on Bone Metastases in Subjects With Breast Cancer

Brief description of study

This is a single arm, open label, pharmacodynamics, intrapatient dose escalation phase 1B study.

Clinical Study Identifier: NCT03292536

Contact Investigators or Research Sites near you

Start Over

Adam Cohen, MD

Huntsman Cancer Institute
Salt Lake City, UT United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.